Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP759422.RAhTls_S2weN8k-dqnyRtf-82UK0eCGXnPGwnfTNennSA130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP759422.RAhTls_S2weN8k-dqnyRtf-82UK0eCGXnPGwnfTNennSA130_assertion type Assertion NP759422.RAhTls_S2weN8k-dqnyRtf-82UK0eCGXnPGwnfTNennSA130_head.
- NP759422.RAhTls_S2weN8k-dqnyRtf-82UK0eCGXnPGwnfTNennSA130_assertion description "[Approximately 30-40% of these tumors exhibit clinical features suggestive of endemic Burkitt lymphoma: they are aggressive malignancies that occur in association with Epstein-Barr virus infection, they arise in the setting of immunosuppression, and they carry t(8;14) translocations without detectable rearrangement of the MYC oncogene.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP759422.RAhTls_S2weN8k-dqnyRtf-82UK0eCGXnPGwnfTNennSA130_provenance.
- NP759422.RAhTls_S2weN8k-dqnyRtf-82UK0eCGXnPGwnfTNennSA130_assertion evidence source_evidence_literature NP759422.RAhTls_S2weN8k-dqnyRtf-82UK0eCGXnPGwnfTNennSA130_provenance.
- NP759422.RAhTls_S2weN8k-dqnyRtf-82UK0eCGXnPGwnfTNennSA130_assertion SIO_000772 2682665 NP759422.RAhTls_S2weN8k-dqnyRtf-82UK0eCGXnPGwnfTNennSA130_provenance.
- NP759422.RAhTls_S2weN8k-dqnyRtf-82UK0eCGXnPGwnfTNennSA130_assertion wasDerivedFrom befree-20140225 NP759422.RAhTls_S2weN8k-dqnyRtf-82UK0eCGXnPGwnfTNennSA130_provenance.
- NP759422.RAhTls_S2weN8k-dqnyRtf-82UK0eCGXnPGwnfTNennSA130_assertion wasGeneratedBy ECO_0000203 NP759422.RAhTls_S2weN8k-dqnyRtf-82UK0eCGXnPGwnfTNennSA130_provenance.